{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T19:51:15Z","timestamp":1787946675266,"version":"build-2784847793"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T00:00:00Z","timestamp":1753228800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Immunology"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.clim.2025.110565","type":"journal-article","created":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T19:20:30Z","timestamp":1752607230000},"page":"110565","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Novel pathogenic variants in CTLA4 and LRBA immune dysregulation: Reduced CTLA-4 expression with normal expression of co-stimulatory surface molecules"],"prefix":"10.1016","volume":"280","author":[{"given":"Samantha A.M.","family":"Tromp","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ester M.M.","family":"van Leeuwen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Machiel H.","family":"Jansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arjan J.","family":"Kwakernaak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marije K.","family":"Bomers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ren\u00e9 E.","family":"Jonkers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Resie M.L.","family":"van Spaendonk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taco W.","family":"Kuijpers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Godelieve J.","family":"de Bree","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.clim.2025.110565_bb0005","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1136\/jmedgenet-2015-103690","article-title":"Genes associated with common variable immunodeficiency: one diagnosis to rule them all?","volume":"53","author":"Bogaert","year":"2016","journal-title":"J. Med. Genet."},{"issue":"4","key":"10.1016\/j.clim.2025.110565_bb0010","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.iac.2015.07.009","article-title":"Common variable immunodeficiency: diagnosis, management, and treatment","volume":"35","author":"Abbott","year":"2015","journal-title":"Immunol. Allergy Clin. North Am."},{"issue":"3","key":"10.1016\/j.clim.2025.110565_bb0015","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.iac.2020.03.001","article-title":"Defining common variable immunodeficiency disorders in 2020","volume":"40","author":"Ameratunga","year":"2020","journal-title":"Immunol. Allergy Clin. North Am."},{"issue":"1","key":"10.1016\/j.clim.2025.110565_bb0020","doi-asserted-by":"crossref","first-page":"14","DOI":"10.18176\/jiaci.0388","article-title":"Common variable immunodeficiency: epidemiology, pathogenesis, clinical manifestations, diagnosis, classification, and management","volume":"30","author":"Yazdani","year":"2020","journal-title":"J. Invest. Allergol. Clin. Immunol."},{"key":"10.1016\/j.clim.2025.110565_bb0025","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.coi.2021.05.010","article-title":"There is no gene for CVID \u2013 novel monogenetic causes for primary antibody deficiency","volume":"72","author":"Ramirez","year":"2021","journal-title":"Curr. Opin. Immunol."},{"issue":"2","key":"10.1016\/j.clim.2025.110565_bb0030","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1111\/cei.13345","article-title":"Transient hypogammaglobulinaemia of infancy: many patients recover in adolescence and adulthood","volume":"198","author":"Ameratunga","year":"2019","journal-title":"Clin. Exp. Immunol."},{"issue":"1","key":"10.1016\/j.clim.2025.110565_bb0035","doi-asserted-by":"crossref","DOI":"10.70962\/jhi.20250002","article-title":"The 2024 update of IUIS phenotypic classification of human inborn errors of immunity","volume":"1","author":"Bousfiha","year":"2025","journal-title":"J. Human Immunity"},{"key":"10.1016\/j.clim.2025.110565_bb0040","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1146\/annurev-pathmechdis-031521-024229","article-title":"Common variable immunodeficiency: more pathways than roads to Rome","volume":"18","author":"Peng","year":"2023","journal-title":"Annu. Rev. Pathol."},{"issue":"12","key":"10.1016\/j.clim.2025.110565_bb0045","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1038\/nm.3746","article-title":"Autosomal dominant immune dysregulation syndrome in humans with CTLA4 mutations","volume":"20","author":"Schubert","year":"2014","journal-title":"Nat. Med."},{"issue":"6","key":"10.1016\/j.clim.2025.110565_bb0050","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1016\/j.jaci.2018.02.055","article-title":"Phenotype, penetrance, and treatment of 133 cytotoxic T-lymphocyte antigen 4-insufficient subjects","volume":"142","author":"Schwab","year":"2018","journal-title":"J. Allergy Clin. Immunol."},{"issue":"2","key":"10.1016\/j.clim.2025.110565_bb0055","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1046\/j.1365-2567.2000.00121.x","article-title":"CD28, CTLA-4 and their ligands: who does what and to whom?","volume":"101","author":"Sansom","year":"2000","journal-title":"Immunology"},{"key":"10.1016\/j.clim.2025.110565_bb0060","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.608024","article-title":"Beyond T-cells: functional characterization of CTLA-4 expression in immune and non-immune cell types","volume":"11","author":"Oyewole-Said","year":"2020","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.clim.2025.110565_bb0065","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/gene.2013.57","article-title":"Differential CTLA-4 expression in human CD4+ versus CD8+ T cells is associated with increased NFAT1 and inhibition of CD4+ proliferation","volume":"15","author":"Chan","year":"2014","journal-title":"Genes Immun."},{"key":"10.1016\/j.clim.2025.110565_bb0070","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/978-981-15-3266-5_2","article-title":"Molecular and cellular functions of CTLA-4","volume":"1248","author":"Van Coillie","year":"2020","journal-title":"Adv. Exp. Med. Biol."},{"issue":"6","key":"10.1016\/j.clim.2025.110565_bb0075","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.it.2008.02.011","article-title":"CTLA-4 trafficking and surface expression","volume":"29","author":"Valk","year":"2008","journal-title":"Trends Immunol."},{"issue":"1","key":"10.1016\/j.clim.2025.110565_bb0080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/cei.12997","article-title":"Immune deficiency and autoimmunity in patients with CTLA-4 (CD152) mutations","volume":"190","author":"Verma","year":"2017","journal-title":"Clin. Exp. Immunol."},{"issue":"9","key":"10.1016\/j.clim.2025.110565_bb0085","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1016\/j.humimm.2013.05.012","article-title":"Kinetics of the CTLA-4 isoforms expression after T-lymphocyte activation and role of the promoter polymorphisms on CTLA-4 gene transcription","volume":"74","author":"Perez-Garcia","year":"2013","journal-title":"Hum. Immunol."},{"issue":"22","key":"10.1016\/j.clim.2025.110565_bb0090","doi-asserted-by":"crossref","first-page":"5155","DOI":"10.1182\/blood-2011-11-388918","article-title":"Basis of CTLA-4 function in regulatory and conventional CD4(+) T cells","volume":"119","author":"Tai","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.clim.2025.110565_bb0095","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1146\/annurev.immunol.24.021605.090535","article-title":"A molecular perspective of CTLA-4 function","volume":"24","author":"Teft","year":"2006","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.clim.2025.110565_bb0100","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.3389\/fimmu.2018.02397","article-title":"LRBA deficiency in a patient with a novel homozygous mutation due to chromosome 4 segmental uniparental Isodisomy","volume":"9","author":"Soler-Palacin","year":"2018","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.clim.2025.110565_bb0105","doi-asserted-by":"crossref","first-page":"236","DOI":"10.25100\/cm.v49i3.3802","article-title":"LRBA in the endomembrane system","volume":"49","author":"Martinez Jaramillo","year":"2018","journal-title":"Colomb. Med. (Cali)"},{"issue":"6204","key":"10.1016\/j.clim.2025.110565_bb0110","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1126\/science.1255904","article-title":"Immune dysregulation in human subjects with heterozygous germline mutations in CTLA4","volume":"345","author":"Kuehn","year":"2014","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.clim.2025.110565_bb0115","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1016\/j.jaci.2018.08.026","article-title":"A novel LPS-responsive beige-like anchor protein (LRBA) mutation presents with normal cytotoxic T lymphocyte-associated protein 4 (CTLA-4) and overactive T(H)17 immunity","volume":"142","author":"De Bruyne","year":"2018","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.clim.2025.110565_bb0120","doi-asserted-by":"crossref","first-page":"998","DOI":"10.3389\/fimmu.2019.00998","article-title":"CTLA4 message reflects pathway disruption in monogenic disorders and under therapeutic blockade","volume":"10","author":"Garcia-Perez","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.clim.2025.110565_bb0125","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.imlet.2017.02.007","article-title":"EFIS lecture: understanding the CTLA-4 checkpoint in the maintenance of immune homeostasis","volume":"184","author":"Walker","year":"2017","journal-title":"Immunol. Lett."},{"issue":"6","key":"10.1016\/j.clim.2025.110565_bb0130","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1007\/s10875-019-00656-x","article-title":"Diagnostic yield of next generation sequencing in genetically undiagnosed patients with primary Immunodeficiencies: a systematic review","volume":"39","author":"Yska","year":"2019","journal-title":"J. Clin. Immunol."},{"issue":"7814","key":"10.1016\/j.clim.2025.110565_bb0135","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/s41586-020-2265-1","article-title":"Whole-genome sequencing of a sporadic primary immunodeficiency cohort","volume":"583","author":"Thaventhiran","year":"2020","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.clim.2025.110565_bb0140","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1007\/s10875-019-00737-x","article-title":"Human inborn errors of immunity: 2019 update on the classification from the International Union of Immunological Societies Expert Committee","volume":"40","author":"Tangye","year":"2020","journal-title":"J. Clin. Immunol."},{"issue":"10","key":"10.1016\/j.clim.2025.110565_bb0145","doi-asserted-by":"crossref","first-page":"5012","DOI":"10.4049\/jimmunol.1201807","article-title":"Identification of B cell defects using age-defined reference ranges for in vivo and in vitro B cell differentiation","volume":"190","author":"Aan de Kerk","year":"2013","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.clim.2025.110565_bb0150","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.jaci.2015.09.025","article-title":"The extended phenotype of LPS-responsive beige-like anchor protein (LRBA) deficiency","volume":"137","author":"Gamez-Diaz","year":"2016","journal-title":"J. Allergy Clin. Immunol."},{"issue":"1","key":"10.1016\/j.clim.2025.110565_bb0155","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s10875-015-0224-7","article-title":"Spectrum of phenotypes associated with mutations in LRBA","volume":"36","author":"Alkhairy","year":"2016","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.clim.2025.110565_bb0160","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.coi.2017.07.014","article-title":"Lessons from CTLA-4 deficiency and checkpoint inhibition","volume":"49","author":"Lo","year":"2017","journal-title":"Curr. Opin. Immunol."},{"issue":"8","key":"10.1016\/j.clim.2025.110565_bb0165","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1182\/blood-2016-04-712612","article-title":"CHAI and LATAIE: new genetic diseases of CTLA-4 checkpoint insufficiency","volume":"128","author":"Lo","year":"2016","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.clim.2025.110565_bb0170","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1016\/j.jaci.2011.07.001","article-title":"A novel mutation in CD132 causes X-CID with defective T-cell activation and impaired humoral reactivity","volume":"128","author":"Kuijpers","year":"2011","journal-title":"J. Allergy Clin. Immunol."},{"issue":"7","key":"10.1016\/j.clim.2025.110565_bb0175","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1007\/s10875-016-0321-2","article-title":"Phenotypic and functional comparison of class switch recombination deficiencies with a subgroup of common variable Immunodeficiencies","volume":"36","author":"Aan de Kerk","year":"2016","journal-title":"J. Clin. Immunol."},{"issue":"10","key":"10.1016\/j.clim.2025.110565_bb0180","doi-asserted-by":"crossref","first-page":"2588","DOI":"10.1111\/j.1600-6143.2012.04180.x","article-title":"The role of costimulatory molecules in directing the functional differentiation of alloreactive T helper cells","volume":"12","author":"Magee","year":"2012","journal-title":"Am. J. Transplant."},{"issue":"7","key":"10.1016\/j.clim.2025.110565_bb0185","doi-asserted-by":"crossref","first-page":"4927","DOI":"10.4049\/jimmunol.177.7.4927","article-title":"ICOS deficiency is associated with a severe reduction of CXCR5+CD4 germinal center Th cells","volume":"177","author":"Bossaller","year":"2006","journal-title":"J. Immunol."},{"issue":"3","key":"10.1016\/j.clim.2025.110565_bb0190","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/ni902","article-title":"Homozygous loss of ICOS is associated with adult-onset common variable immunodeficiency","volume":"4","author":"Grimbacher","year":"2003","journal-title":"Nat. Immunol."},{"issue":"9","key":"10.1016\/j.clim.2025.110565_bb0195","doi-asserted-by":"crossref","first-page":"4217","DOI":"10.4049\/jimmunol.1102885","article-title":"CD80 expression on B cells regulates murine T follicular helper development, germinal center B cell survival, and plasma cell generation","volume":"188","author":"Good-Jacobson","year":"2012","journal-title":"J. Immunol."},{"issue":"2","key":"10.1016\/j.clim.2025.110565_bb0200","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S1074-7613(02)00362-X","article-title":"The interaction properties of costimulatory molecules revisited","volume":"17","author":"Collins","year":"2002","journal-title":"Immunity"},{"issue":"6828","key":"10.1016\/j.clim.2025.110565_bb0205","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1038\/35069112","article-title":"Structural basis for co-stimulation by the human CTLA-4\/B7-2 complex","volume":"410","author":"Schwartz","year":"2001","journal-title":"Nature"},{"issue":"6828","key":"10.1016\/j.clim.2025.110565_bb0210","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1038\/35069118","article-title":"Crystal structure of the B7-1\/CTLA-4 complex that inhibits human immune responses","volume":"410","author":"Stamper","year":"2001","journal-title":"Nature"},{"issue":"11","key":"10.1016\/j.clim.2025.110565_bb0215","doi-asserted-by":"crossref","first-page":"7316","DOI":"10.4049\/jimmunol.179.11.7316","article-title":"A new role of CTLA-4 on B cells in thymus-dependent immune responses in vivo","volume":"179","author":"Quandt","year":"2007","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2025.110565_bb0220","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.clim.2018.01.001","article-title":"Study of an extended family with CTLA-4 deficiency suggests a CD28\/CTLA-4 independent mechanism responsible for differences in disease manifestations and severity","volume":"188","author":"Hou","year":"2018","journal-title":"Clin. Immunol."},{"issue":"6246","key":"10.1016\/j.clim.2025.110565_bb0225","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1126\/science.aaa1663","article-title":"Autoimmune Disease. Patients with LRBA deficiency show CTLA4 loss and immune dysregulation responsive to abatacept therapy","volume":"349","author":"Lo","year":"2015","journal-title":"Science"}],"container-title":["Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661625001408?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661625001408?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T18:40:57Z","timestamp":1759862457000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521661625001408"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":45,"alternative-id":["S1521661625001408"],"URL":"https:\/\/doi.org\/10.1016\/j.clim.2025.110565","relation":{},"ISSN":["1521-6616"],"issn-type":[{"value":"1521-6616","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel pathogenic variants in CTLA4 and LRBA immune dysregulation: Reduced CTLA-4 expression with normal expression of co-stimulatory surface molecules","name":"articletitle","label":"Article Title"},{"value":"Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clim.2025.110565","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"110565"}}